The effects of specific medical conditions on the functional limitations of elders in the Framingham Study

A A Guccione, D T Felson, J J Anderson, J M Anthony, Y Zhang, P W Wilson, M Kelly-Hayes, P A Wolf, B E Kreger, W B Kannel, A A Guccione, D T Felson, J J Anderson, J M Anthony, Y Zhang, P W Wilson, M Kelly-Hayes, P A Wolf, B E Kreger, W B Kannel

Abstract

Objectives: The purpose of this study was to identify associations between specific medical conditions in the elderly and limitations in functional tasks; to compare risks of disability across medical conditions, controlling for age, sex, and comorbidity; and to determine the proportion of disability attributable to each condition.

Methods: The subjects were 709 noninstitutionalized men and 1060 women of the Framingham Study cohort (mean age 73.7 +/- 6.3 years). Ten medical conditions were identified for study: knee osteoarthritis, hip fracture, diabetes, stroke, heart disease, intermittent claudication, congestive heart failure, chronic obstructive pulmonary disease, depressive symptomatology, and cognitive impairment. Adjusted odds ratios were calculated for dependence on human assistance in seven functional activities.

Results: Stroke was significantly associated with functional limitations in all seven tasks; depressive symptomatology and hip fracture were associated with limitations in five tasks; and knee osteoarthritis, heart disease, congestive heart failure, and chronic obstructive pulmonary disease, were associated with limitations in four tasks each.

Conclusions: In general, stroke, depressive symptomatology, hip fracture, knee osteoarthritis, and heart disease account for more physical disability in noninstitutionalized elderly men and women than other diseases.

References

    1. Am J Epidemiol. 1986 Sep;124(3):372-88
    1. Am J Epidemiol. 1985 Oct;122(4):644-56
    1. J Clin Epidemiol. 1988;41(8):719-26
    1. Am J Epidemiol. 1988 Nov;128(5):1084-101
    1. Am J Public Health. 1989 Jun;79(6):698-702
    1. Am J Public Health. 1989 Jun;79(6):703-8
    1. Am J Epidemiol. 1989 Jul;130(1):66-78
    1. JAMA. 1989 Aug 18;262(7):907-13
    1. JAMA. 1989 Aug 18;262(7):914-9
    1. J Clin Epidemiol. 1989;42(9):895-904
    1. J Gerontol. 1990 Jan;45(1):M3-11
    1. J Gerontol. 1990 Mar;45(2):S60-8
    1. J Gerontol. 1990 May;45(3):M101-7
    1. Milbank Q. 1989;67(3-4):450-84
    1. Am J Public Health. 1990 Aug;80(8):945-9
    1. Arthritis Rheum. 1990 Aug;33(8):1205-15
    1. J Gerontol. 1990 Sep;45(5):M163-8
    1. Am J Public Health. 1990 Nov;80(11):1363-7
    1. J Clin Epidemiol. 1991;44(2):167-82
    1. J Gerontol. 1991 Mar;46(2):S71-83
    1. Neurology. 1992 Jan;42(1):115-9
    1. Am J Public Health. 1992 Jun;82(6):841-5
    1. J Gerontol. 1966 Oct;21(4):556-9
    1. Milbank Mem Fund Q Health Soc. 1976 Fall;54(4):439-67
    1. Am J Public Health. 1981 Nov;71(11):1202-10
    1. Stat Med. 1984 Apr-Jun;3(2):131-41
    1. J Am Geriatr Soc. 1985 Jan;33(1):23-8
    1. Arch Phys Med Rehabil. 1988 Jun;69(6):415-8

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅